Dementias Terminated Phase 4 Trials for Methylphenidate (DB00422)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01825577Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.Prevention